Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_assertion type Assertion NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_head.
- NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_provenance.
- NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_assertion evidence source_evidence_literature NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_provenance.
- NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_assertion SIO_000772 23497317 NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_provenance.
- NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_assertion wasDerivedFrom befree-20140225 NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_provenance.
- NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_assertion wasGeneratedBy ECO_0000203 NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_provenance.